Gainers / Losers
Enter Company or MF
e.g. Tata motors, Reliance MF, 500570
Dr.reddy's Laboratories Ltd.
Dr. Reddys enters the branded consumer health arena through the acquisition of six OTC brands
Board recommends Final Dividend
Announces Q4 & FY16 Results (Standalone & Consolidated), Form A (Standalone & Consolidated), Auditors Report (Standalone & Consolidated) & Results Press Release for the period ended March 31, 2016
Appointment of Additional Independent Director
Dr. Reddys to release Q4 and Full Year FY16 results on May 12, 2016 // Earnings call slated for May 12, 6.30 PM IST / 9.00 AM EDT
Closure of Trading Window
FY16 results on May 12, 2016
ZEMBRACE" SymTouch" (sumatriptan injection) 3 mg, approved by the FDA in January 2016 for the acute treatment of migraine with or without aura in adults, is now commercially available in the U.S.
Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015 for Quarter ended March 31, 2016
Buy Back Offer
View announcements for all companies
Mutual Fund Selector
Find the fund that is right for you
Buy? Sell? Hold?
Get the Latest Stock Tips
ALL MONEYWIZ PAGES
Similar Price band
Most traded - By volumes
Top 100 - By market capitalisation
Latest Company Results
Top 25 schemes
Funds of Funds
Dynamic Asset Allocation
Equity - ELSS
Equity - Index Funds
Equity - Sector Funds
Equity - Balance Fund
Equity - Diversified Fund
My Watch List
If You Had Invested...
© 2016 Rediff.com India Limited. All rights reserved.
Terms of Service